Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$423M |
| 2 |
CS
Credit Suisse Group
CS
|
+$261M |
| 3 |
Barclays
BCS
|
+$240M |
| 4 |
ABB
ABB Ltd
ABB
|
+$161M |
| 5 |
Trip.com Group
TCOM
|
+$113M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lloyds Banking Group
LYG
|
+$230M |
| 2 |
SI
SIEMENS AKTIENGESELLSCHAFT ADS
SI
|
+$162M |
| 3 |
BF
BASF AKTIENGESELLT ADS(RP1 ORD
BF
|
+$84M |
| 4 |
BHP
BHP
|
+$60.3M |
| 5 |
SUSQ
SUSQUEHANNA BANCSHARES INC
SUSQ
|
+$42.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.7% |
| 2 | Healthcare | 13.73% |
| 3 | Technology | 13.21% |
| 4 | Industrials | 7.16% |
| 5 | Consumer Discretionary | 6.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBD
176
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $32.2M | 0.07% |
874,436
+464,732
| +113% | +$18.8M |
|
177
Boeing
BA
$175B
| $32M | 0.07% |
245,889
+1,252
| +0.5% | +$159K |
|
178
Polaris
PII
$3.88B
| $31.8M | 0.07% |
210,323
-5,307
| -2% | -$796K |
|
|
EDR
179
DELISTED
Education Realty Trust Inc
EDR
| $31.7M | 0.07% |
867,132
-18,772
| -2% | -$643K |
|
180
Avista
AVA
$3.39B
| $30.4M | 0.06% |
861,250
-10,065
| -1% | -$343K |
|
181
Integer Holdings
ITGR
$3.42B
| $30.4M | 0.06% |
676,116
+7,416
| +1% | +$324K |
|
182
United Natural Foods
UNFI
$3.01B
| $30.1M | 0.06% |
389,552
+1,262
| +0.3% | +$89.2K |
|
183
Primerica
PRI
$10.1B
| $30M | 0.06% |
553,726
+67,584
| +14% | +$3.44M |
|
184
Helmerich & Payne
HP
$3.37B
| $30M | 0.06% |
444,952
+2,079
| +0.5% | +$162K |
|
|
INVX
185
Innovex International
INVX
$1.85B
| $29.2M | 0.06% |
380,854
+18,930
| +5% | +$1.58M |
|
186
Integra LifeSciences
IART
$1.33B
| $29.1M | 0.06% |
1,314,061
-29,089
| -2% | -$590K |
|
|
FIBG
187
DELISTED
CS FI Enhanced Big Cap Growth ETN
FIBG
| $28.8M | 0.06% |
520,681
-7,558
| -1% | -$398K |
|
188
Extra Space Storage
EXR
$31.3B
| $28.5M | 0.06% |
485,465
+9,843
| +2% | +$564K |
|
189
Capitol Federal Financial
CFFN
$1.1B
| $27.3M | 0.06% |
2,134,026
-42,990
| -2% | -$539K |
|
190
Biogen
BIIB
$30.7B
| $26.9M | 0.06% |
79,254
+797
| +1% | +$258K |
|
191
Revvity
RVTY
$12.7B
| $26.7M | 0.06% |
611,262
-3,267
| -0.5% | -$141K |
|
192
State Street Financial Select Sector SPDR ETF
XLF
$56.8B
| $25.9M | 0.05% |
1,195,158
+55,515
| +5% | +$1.16M |
|
193
iShares MSCI Germany ETF
EWG
$1.6B
| $25.8M | 0.05% |
+941,819
| New | +$25.7M |
|
194
MKS Inc
MKSI
$19.8B
| $25.8M | 0.05% |
705,159
-10,950
| -2% | -$387K |
|
195
eBay
EBAY
$50.4B
| $25.8M | 0.05% |
1,092,029
+7,948
| +0.7% | +$180K |
|
|
CELG
196
DELISTED
Celgene Corp
CELG
| $25.4M | 0.05% |
227,331
-4,806
| -2% | -$507K |
|
197
Amgen
AMGN
$209B
| $24.6M | 0.05% |
154,439
-2,190
| -1% | -$341K |
|
198
Charles River Laboratories
CRL
$11.3B
| $24.4M | 0.05% |
383,102
+14,894
| +4% | +$934K |
|
199
Union Pacific
UNP
$172B
| $22.5M | 0.05% |
188,558
-3,526
| -2% | -$405K |
|
200
Ford
F
$59.3B
| $21.8M | 0.05% |
1,406,301
+7,160
| +0.5% | +$106K |
|
Similar funds
Ken Fisher's Q4 2014 Portfolio in Review
As of Q4 2014, Ken Fisher held 664 positions worth $48.4B, up 3.1% from $46.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Ken Fisher's Q4 2014 filing shows 80 new, 228 increased, 245 reduced and 44 closed positions. Its largest new stake was UBS Group: 24,721,456 shares worth $422M. The largest sale was Lloyds Banking Group, an estimated $230M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.
- Ken Fisher's largest Q4 2014 buy was UBS Group: 24,721,456 shares worth $422M.
- Ken Fisher added most to Credit Suisse Group in Q4 2014, an estimated $261M increase.
- Ken Fisher's biggest Q4 2014 reduction was Lloyds Banking Group, cutting an estimated $230M.
- Ken Fisher fully exited SUSQUEHANNA BANCSHARES INC in Q4 2014, selling an estimated $42.8M.
- Ken Fisher's ten largest holdings make up 22% of its $48.4B portfolio in Q4 2014.
- Ken Fisher opened 80 new positions and closed 44 in Q4 2014.
- Ken Fisher's portfolio value rose 3.1% quarter-over-quarter to $48.4B.
Based on Fisher Asset Management's 13F filing for Q4 2014, filed 29 Jan 2015.